Tate Wesley D. 4
4 · CEREBAIN BIOTECH CORP. · Filed Sep 25, 2018
Insider Transaction Report
Form 4
Tate Wesley D.
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2018-02-19$0.18/sh+160,000$28,800→ 782,230 total
Footnotes (1)
- [F1]The Reporting Person was issued the shares from the Issuer in lieu of compensation for services valued at $28,800.